Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment
Journal of Comparative Effectiveness Research · 2025
DOI: 10.57264/cer-2025-0097 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Tao Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi Province, China. Hauptthemen laut MEDLINE: Craniotomy, Basal Ganglia Hemorrhage, Drainage, Conservative Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
The optimal management strategies for spontaneous intracerebral hemorrhage in the basal ganglia region are still controversial. The purpose of the present study is to evaluate the clinical benefits of craniotomy, minimally invasive puncture and drainage (MIPD) and conservative treatment in patients with basal ganglia hematoma. Materials & methods: This study retrospectively enrolled consecutive patients with hematoma ≥20 ml in the basal ganglia hemorrhage and onset to admission within 24 h. Primary outcome was the proportion of favorable outcome (modified Rankin scale score 0–3) at 3 months. Secondary outcomes included excellent outcome (modified Rankin scale score 0–2) and mortality at 3 months and 1 year. Sensitive analysis was performed in patients with hematoma ≥ 30 ml.
Results
A total of 481 patients were included and divided into three groups: 146 received craniotomy, 211 underwent MIPD and 124 were managed with conservative treatment. The proportion of primary outcome was lower in the craniotomy (23.24%) than in the MIPD (35.41%) and conservative treatment (41.94%) groups. Among patients with hematoma ≥30 ml, MIPD has higher rates of favorable outcome at 3 months (37.32 vs 25.98%, p = 0.05) and 1 year (52.82 vs 40.16%, p = 0.04) compared with craniotomy; albeit. The short-term and long-term mortality was similar in three groups.
Conclusion
MIPD was found to be associated with both short- and long-term favorable outcomes in patients with spontaneous intracerebral hemorrhage in the basal ganglia region. Moreover, neither MIPD nor craniotomy showed an association with increased risk of short- or long-term mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi Province, China.
- Department of Neurology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi Province, China.
- Department of Neurosurgery, The First Hospital of Yulin & The Second Affiliated Hospital, Yan'an University, Yulin 719000, Shaanxi Province, China.
- Department of Neurology, Xianyang Hospital of Yan'an University, Xianyang 712000, Shaanxi Province, China.
- Department of Blood Transfusion, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi Province, China.
ORCID-Profile: Tao Tang, Jing Liu, Bo Gao, Yu Gao, Gaopan Zhang, Gang Guo
Zitieren
APA
Tang, T., Liu, J., Gao, B., Gao, Y., Zhang, G., & Guo, G. (2025). Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2025-0097
Vancouver
Tang T, Liu J, Gao B, Gao Y, Zhang G, Guo G. Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2025-0097
BibTeX
@article{Tang2025,
author = {Tang, Tao and Liu, Jing and Gao, Bo and Gao, Yu and Zhang, Gaopan and Guo, Gang},
title = {Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment},
journal = {Journal of Comparative Effectiveness Research},
year = {2025},
doi = {10.57264/cer-2025-0097}
}
EUVIMED